Company / Operating Income per Share
ADC Therapeutics SA Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.23
FY2025
5-year range
-$2.02 / -$1.23
FY2023-FY2025
Trend
+39.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.53 to $-1.23 over the past 2 years.
Based on SEC 10-K filings.
-1.23 in FY2025.
Improved from $-1.53 to $-1.23 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 39.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.23 | +39.1% |
| FY2024 | -$2.02 | -31.9% |
| FY2023 | -$1.53 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026